Comparative Brain Exposure to (-)-carbovir After (-)-carbovir or (-)-6-aminocarbovir Intravenous Infusion in Rats

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 1995 Jun 1

PMID 7667200

Authors

Y D Wen

R P Remmel

P T Pham

R Vince

C L Zimmerman

Affiliations

Soon will be listed here.

Abstract

Purpose: Evaluate the ability of (-)-6-aminocarbovir ((-)-6AC) to improve the CNS exposure to (-)-carbovir ((-)-CBV).

Methods: Activation of (-)-6AC in vitro was assessed by incubations of rat brain tissue homogenates. The in vivo brain exposure to (-)-CBV was then examined in rats after iv infusions of either (-)-CBV (n = 4) or (-)-6AC (n = 5). The drugs were infused to steady-state via the jugular vein. At the end of the infusion, a bolus of [3H]inulin was injected via the femoral vein in order to obtain an estimate of the brain vascular space.

Results: (-)-6AC was converted to (-)-CBV by incubations of rat brain tissue homogenates. After iv infusion of (-)-CBV, the brain/blood concentration ratio of (-)-CBV was 0.032 +/- 0.009. The brain/blood concentration ratio of (-)-CBV after iv infusion of (-)-6AC was 0.080 +/- 0.020.

Conclusions: (-)-6AC improved the brain delivery of (-)-CBV, although the absolute exposure of the brain tissue to (-)-CBV was still quite low.

References

Terasaki T, Pardridge W . Restricted transport of 3'-azido-3'-deoxythymidine and dideoxynucleosides through the blood-brain barrier. J Infect Dis. 1988; 158(3):630-2. DOI: 10.1093/infdis/158.3.630. View

Price R, Brew B, Sidtis J, Rosenblum M, Scheck A, Cleary P . The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 1988; 239(4840):586-92. DOI: 10.1126/science.3277272. View

Morgan M, Chi S, Murakami K, Mitsuya H, Anderson B . Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs. Antimicrob Agents Chemother. 1992; 36(10):2156-65. PMC: 245470. DOI: 10.1128/AAC.36.10.2156. View

Ho D, PINCUS C, Carter C, Benjamin R, Freireich E, Bodey Sr G . Distribution and inhibition of adenosine deaminase in tissues of man, rat, and mouse. Cancer Treat Rep. 1980; 64(4-5):629-33. View

Zimmerman C, Remmel R, Ibrahim S, Beers S, Vince R . Pharmacokinetic evaluation of (-)-6-aminocarbovir as a prodrug for (-)-carbovir in rats. Drug Metab Dispos. 1992; 20(1):47-51. View

Chu C, Bhadti V, Doshi K, Etse J, Gallo J, Boudinot F . Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine. J Med Chem. 1990; 33(8):2188-92. DOI: 10.1021/jm00170a023. View

Vince R, Hua M . Synthesis and anti-HIV activity of carbocyclic 2',3'-didehydro-2',3'-dideoxy 2,6-disubstituted purine nucleosides. J Med Chem. 1990; 33(1):17-21. DOI: 10.1021/jm00163a004. View

Galinsky R, Hoesterey B, Anderson B . Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection. Life Sci. 1990; 47(9):781-8. DOI: 10.1016/0024-3205(90)90550-b. View

Galinsky R, Flaharty K, Hoesterey B, Anderson B . Probenecid enhances central nervous system uptake of 2',3'-dideoxyinosine by inhibiting cerebrospinal fluid efflux. J Pharmacol Exp Ther. 1991; 257(3):972-8. View

10.

Namane A, Gouyette C, Fillion M, Fillion G, Huynh-Dinh T . Improved brain delivery of AZT using a glycosyl phosphotriester prodrug. J Med Chem. 1992; 35(16):3039-44. DOI: 10.1021/jm00094a018. View

11.

Brouwer K, St Claire R, Lagarde J, Patanella J, Walsh J, Miwa G . The pharmacokinetics of (-)-carbovir in rats. Evidence for nonlinear elimination. Drug Metab Dispos. 1990; 18(6):1078-83. View

12.

Vince R, Brownell J . Resolution of racemic carbovir and selective inhibition of human immunodeficiency virus by the (-) enantiomer. Biochem Biophys Res Commun. 1990; 168(3):912-6. DOI: 10.1016/0006-291x(90)91115-9. View

13.

Lupia R, Ferencz N, Lertora J, Aggarwal S, George W, Agrawal K . Comparative pharmacokinetics of two prodrugs of zidovudine in rabbits: enhanced levels of zidovudine in brain tissue. Antimicrob Agents Chemother. 1993; 37(4):818-24. PMC: 187771. DOI: 10.1128/AAC.37.4.818. View

14.

Vince R, Hua M, Brownell J, Daluge S, Lee F, SHANNON W . Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro. Biochem Biophys Res Commun. 1988; 156(2):1046-53. DOI: 10.1016/s0006-291x(88)80950-1. View

15.

Remmel R, Huang S, Hoff D, Zimmerman C . Improved fluorometric high-performance liquid chromatographic assay for (-)-carbovir in rat blood and urine. J Chromatogr. 1990; 534:109-18. DOI: 10.1016/s0378-4347(00)82153-2. View

16.

Remmel R, Yeom Y, Hua M, Vince R, Zimmerman C . Liquid chromatographic assay of carbovir, a carbocyclic nucleoside active against human immunodeficiency virus. J Chromatogr. 1989; 489(2):323-31. DOI: 10.1016/s0378-4347(00)82910-2. View

17.

Huang S, Remmel R, Zimmerman C . The bioavailability and nonlinear clearance of (-)-carbovir in the rat. Pharm Res. 1991; 8(6):739-43. DOI: 10.1023/a:1015850017201. View

18.

Anderson B, Hoesterey B, Baker D, Galinsky R . Uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies. J Pharmacol Exp Ther. 1990; 253(1):113-8. View

19.

Black P . HTLV-III, AIDS, and the brain. N Engl J Med. 1985; 313(24):1538-40. DOI: 10.1056/NEJM198512123132409. View